Poor distribution delays drug arrival for a year and a half: manufacturers

Multiple failures in the supply chain, specifically in distribution, has caused some drugs to take up to a year and a half to reach hospitals and health centers that request them, warned the National Association of Drug Manufacturers (ANAFAM)
During a round table convened by the National Association of Distributors of Health Supplies (ANDIS) to discuss health regulation in the supply chain, Carlos Villaseñor, president of the ANAFAM supply committee, reproached the opacity of the authorities that does not allow them to know where the medicines they deliver to logistics operators for distribution to health institutions that require them are.
He shared that a few days ago one of his associates informed him that the medicine he delivered to the authorities in a timely manner took a year and a half to reach its destination. Even, already with the expiration date very close.

“(Medicines) are delivered with logistics operators and from there we lose traceability (…) we have no possibility of knowing in detail, as we knew before, where they are. Just a few days ago, a colleague told me that his product arrived after a year and a half where they were waiting for it,” Villaseñor shared.
“All these times are a reality. There is an important problem of information and there is a significant problem of capacity and above all of displacement of the product to the places where it has to be used, “he reproached.
Read more | Shortage of medicines and lack of care in institutions increases out-of-pocket spending on health by up to 40%.

And it is that the current administration, accusing very high costs in the purchase and distribution of medicines, chose to divide the procedures and on the one hand acquire the medicines and on the other, order their distribution to other companies.
This process, which is carried out with the guidance of UNOPS, has resulted in a series of complications that have resulted in medicines not arriving in a timely manner to health institutions to be delivered to the population, or to arrive expired or with a date very close to being fulfilled.
“After a while they will want to return all that product (…) and those who have the least blame (we have) are the producers who have delivered in a timely manner,” Villaseñor said.
Therefore, the representatives of the pharmaceutical industry called on the health authorities to comply and verify the correct compliance with the current regulation so that it is not only guaranteed that the medicines reach the population, but that they do so in ideal conditions.
That the cold nets are adequate, that the products are handled correctly, that they have an expiration date and batch, that the hygiene conditions of the products are verified and that those in charge of transporting the medicines are trained were some of his reflections.
And, they pointed out, the lack of timely access to medicines, in most cases because they are not being distributed correctly, causes people to acquire expired medicines in tianguis or, for example, to buy (without warning) pirate medicines that put their health at risk.
What we do at Animal Político requires professional journalists, teamwork, dialogue with readers and something very important: independence. You can help us keep going. Be part of the team.
Subscribe to Animal Político, receive benefits and support free journalism.#YoSoyAnimal

Original source in Spanish

Related Posts

Add Comment